annual cash & cash equivalents:
$7.74B-$1.89B(-19.58%)Summary
- As of today (May 29, 2025), SNY annual cash & cash equivalents is $7.74 billion, with the most recent change of -$1.89 billion (-19.58%) on December 31, 2024.
- During the last 3 years, SNY annual cash & cash equivalents has fallen by -$3.69 billion (-32.28%).
- SNY annual cash & cash equivalents is now -43.31% below its all-time high of $13.66 billion, reached on December 31, 2022.
Performance
SNY Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$8.65B+$906.02M(+11.70%)Summary
- As of today (May 29, 2025), SNY quarterly cash & cash equivalents is $8.65 billion, with the most recent change of +$906.02 million (+11.70%) on March 31, 2025.
- SNY quarterly cash & cash equivalents is now -51.84% below its all-time high of $17.96 billion, reached on June 30, 2020.
Performance
SNY quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
SNY Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -19.6% | - |
| 3 y3 years | -32.3% | - |
| 5 y5 years | -26.7% | - |
SNY Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -43.3% | at low | -36.7% | +20.0% |
| 5 y | 5-year | -43.3% | at low | -51.8% | +20.0% |
| alltime | all time | -43.3% | +6976.2% | -51.8% | +6865.9% |
SNY Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $8.65B(+11.7%) |
| Dec 2024 | $7.74B(-19.6%) | $7.74B(+6.3%) |
| Jun 2024 | - | $7.28B(-24.4%) |
| Dec 2023 | $9.63B(-29.5%) | $9.63B(+10.8%) |
| Jun 2023 | - | $8.69B(-36.4%) |
| Dec 2022 | $13.66B(+19.5%) | $13.66B(+89.5%) |
| Jun 2022 | - | $7.21B(-37.0%) |
| Dec 2021 | $11.43B(-7.9%) | $11.43B(-1.2%) |
| Jun 2021 | - | $11.57B(-35.6%) |
| Dec 2020 | $12.42B(+17.6%) | - |
| Jun 2020 | - | $17.96B(+70.1%) |
| Dec 2019 | $10.56B(+33.3%) | $10.56B(+37.8%) |
| Jun 2019 | - | $7.67B(-3.2%) |
| Dec 2018 | $7.92B(-36.0%) | $7.92B(-8.6%) |
| Jun 2018 | - | $8.66B(-30.0%) |
| Dec 2017 | $12.37B(+13.9%) | $12.37B(-0.5%) |
| Jun 2017 | - | $12.44B(+14.6%) |
| Dec 2016 | $10.86B(+8.6%) | $10.86B(+60.7%) |
| Jun 2016 | - | $6.76B(-32.4%) |
| Dec 2015 | $10.00B(+12.0%) | $10.00B(+89.7%) |
| Jun 2015 | - | $5.27B(-40.9%) |
| Dec 2014 | $8.93B(-21.7%) | $8.93B(+52.0%) |
| Jun 2014 | - | $5.87B(-48.5%) |
| Dec 2013 | $11.40B(+35.1%) | $11.40B(+109.2%) |
| Jun 2013 | - | $5.45B(-35.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2012 | $8.44B(+58.0%) | $8.44B(+57.5%) |
| Jun 2012 | - | $5.36B(+0.3%) |
| Dec 2011 | $5.34B(-37.9%) | $5.34B(-43.6%) |
| Jun 2011 | - | $9.47B(+10.1%) |
| Dec 2010 | $8.60B(+28.1%) | $8.60B(+118.3%) |
| Jun 2010 | - | $3.94B(-41.3%) |
| Dec 2009 | $6.71B(+13.6%) | $6.71B(-23.1%) |
| Jun 2009 | - | $8.72B(+47.7%) |
| Dec 2008 | $5.91B(+136.5%) | $5.91B(+296.1%) |
| Jun 2008 | - | $1.49B(-40.3%) |
| Dec 2007 | $2.50B(+64.1%) | $2.50B(+70.4%) |
| Jun 2007 | - | $1.47B(-3.7%) |
| Dec 2006 | $1.52B(+3.0%) | $1.52B(+2.5%) |
| Jun 2006 | - | $1.48B(+0.5%) |
| Dec 2005 | $1.48B(-40.7%) | $1.48B(-45.9%) |
| Jun 2005 | - | $2.73B(+9.5%) |
| Dec 2004 | $2.49B(+1206.2%) | $2.49B(+1431.8%) |
| Jun 2004 | - | $162.77M(-14.7%) |
| Dec 2003 | $190.88M(+26.5%) | $190.88M(+53.7%) |
| Jun 2003 | - | $124.16M(-17.7%) |
| Dec 2002 | $150.95M(+38.0%) | $150.95M(-20.9%) |
| Jun 2002 | - | $190.88M |
| Dec 2001 | $109.42M(-43.7%) | - |
| Dec 2000 | $194.41M(-4.2%) | - |
| Dec 1999 | $203.03M | - |
FAQ
- What is Sanofi annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Sanofi?
- What is Sanofi annual cash & cash equivalents year-on-year change?
- What is Sanofi quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for Sanofi?
What is Sanofi annual cash & cash equivalents?
The current annual cash & cash equivalents of SNY is $7.74B
What is the all time high annual cash & cash equivalents for Sanofi?
Sanofi all-time high annual cash & cash equivalents is $13.66B
What is Sanofi annual cash & cash equivalents year-on-year change?
Over the past year, SNY annual cash & cash equivalents has changed by -$1.89B (-19.58%)
What is Sanofi quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of SNY is $8.65B
What is the all time high quarterly cash & cash equivalents for Sanofi?
Sanofi all-time high quarterly cash & cash equivalents is $17.96B